title: Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
authors.affiliation: Mayo Clinic, Rochester, MN 55905, USA. camilleri.michael@mayo.edu
authors.forename: M
authors.initials: M
authors.lastname: Camilleri
authors.forename: M J
authors.initials: MJ
authors.lastname: Van Outryve
authors.forename: G
authors.initials: G
authors.lastname: Beyens
authors.forename: R
authors.initials: R
authors.lastname: Kerstens
authors.forename: P
authors.initials: P
authors.lastname: Robinson
authors.forename: L
authors.initials: L
authors.lastname: Vandeplassche
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001572:Benzofurans / Q000627:therapeutic use*; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy*; D003672:Defecation / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D054368:Laxatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D058828:Serotonin 5-HT4 Receptor Agonists / Q000627:therapeutic use*; D013223:Statistics as Topic; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D001572:Benzofurans; D054368:Laxatives; D058828:Serotonin 5-HT4 Receptor Agonists; C406662:prucalopride